Updates in the Treatment and Management of Bladder Cancer

By Integrity CE FEATURING Matthew Galsky, Brendan Guercio

283 views

August 2, 2024

Comments 0

2024 Upstate NY Cancer Symposium

Management of mNSCLC Without Actionable Mutations

Integrity CE

M. Baumgart, S. Liu

116 views

Overview of ES/LS-SCLC & New Data

Integrity CE

A. Patel, M. Baumgart, S. Liu, G. Dy

189 views

Management of Stage IV NSCLC With Actionable Mutations

Integrity CE

G. Dy

170 views

Treatment Updates and Management of Hodgkin Lymphoma

Integrity CE

A. Niu, D. Wallace, M. Cortese

149 views

Current Updates in the Management of NDMM

Integrity CE

J. Hillengass, S. Usmani

81 views

Clinical Practice Updates in CLL/SLL

Integrity CE

M. Cortese, D. Wallace, A. Niu

324 views

Treatment Strategies for R/R MM After Frontline Anti-CD38 Therapy

Integrity CE

S. Usmani, J. Hillengass

209 views

How the Experts Treat: Early Stage NSCLC With Curative Intent

Integrity CE

S. Liu

144 views

Treatment Updates and Management of Non-Hodgkin Lymphomas

Integrity CE

D. Wallace, M. Cortese

98 views

2024 Updates on Myeloproliferative Neoplasms, PV, and ET

Integrity CE

A. Tefferi

270 views

Updates in the Treatment and Management of RCC

Integrity CE

B. Guercio, M. Galsky, S. Kadambi

84 views

Clinical Roundtable: Updates on Treatment of HER2+ BC

Integrity CE

S. Dent, S. Graff, S. Gandhi

216 views

Clinical Roundtable: HR+ BC Early Stage & Metastatic Disease Updates

Integrity CE

S. Graff, S. Dent, S. Gandhi

222 views

How the Experts Treat: Updates on TNBC Management

Integrity CE

S. Gandhi, S. Graff, S. Dent

189 views

Updates in the Treatment and Management of Prostate Cancer

Integrity CE

S. Kadambi, B. Guercio, M. Galsky

143 views